Overview
Newskinsolutions conducts research on recombinant endolysins for dermocosmetic and medical use, as well as on culturing human skin cells, particularly fibroblasts. It offers OIN regenerative suppositories and VIN regenerative globules designed to support skin elasticity and soothe the skin. The company also provides access to payload space and biotechnology research under suborbital rocket flight conditions.
Financials
Revenue history
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 4 of 4 financial statements were filed late (the longest delay 478 days for 2021).
- 2025not filed
- 202418/03/2026
- 202322/07/2024
- 202205/11/2023
- 202105/11/2023
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Offer
- Biotechnology research
- Skin cell culture
- Recombinant endolysins
- Regenerative suppositories
- Regenerative globules
Website technology
- Online shop
- WooCommerce
- Website
- WordPress
- Elementor
Authorized Representatives
Manner of representation
In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Dorota Barbara Bądziulage 43 | 10 | $135.06 | 10% |
Agnieszka Ewa Jasińskaage 48 | 90 | $1,215.56 | 90% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2022-03-07.
09 1050 1953 1000 0090 3261 8572
Debt
No entries in the National Debtors Register (KRZ).
Public aid
4 public aid cases recorded, with a total value of $270,478.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Aug 26, 2024 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $2,156$2,156 | Marszałek Województwa Lubelskiego | |
| Mar 11, 2022 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $538$538 | Marszałek Województwa Lubelskiego | |
| Dec 15, 2021 | Aid for SME access to finance — aid for start-ups | $258.6K$258,635 | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2022-01-01 | Optimization of the skin-regenerating properties in the reconstruction of human skin and epidermis using patients’ autologous tissues and stem cells on an artificial skin model | $224.2K$224,226 | Operational Programme Eastern Poland |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| InventionbioS.A. | $17,762,977.76 | inventionbio.pl | ||
| BiotechnaS.A. | $2,472,888.07 | bsbiotechna.com | ||
| SkinlabP.S.A. | $2,218,926.75 | skinlab.pl | ||
| Medicofarma BiotechS.A. | $314,882.33 | medicofarmabiotech.pl | ||
| SKIN Lab Internationalsp. z o.o. | $295,930.15 | skinlab.pl | ||
| FcbiotechS.A. | $246,877.92 | fcbiotech.pl | ||
| Nexbiosp. z o.o. | $186,582.40 | nexbio.pl | ||
| Biostat Research and Developmentsp. z o.o. | $50,225.77 | biostat.com.pl | ||
| Fusiomicasp. z o.o. | $5,263.98 | fusiomica.com | ||
| Genovaris Medicalsp. z o.o. | $25.11 | genovaris.com |
FAQ
Last updated: 2026-04-24